Basic Information

Reference Number

PW-22-01005572

Issuing Organization

Department of National Defence

Owner Organization

Department of National Defence

Solicitation Type

RFP - Request for Proposal (Formal)

Solicitation Number

W6369-23-A056

Title

Doxycycline Hyclate Tablets or Capsules, 100 mg (W6369-23-A056)

Source ID

PWGSC

Agreement Types

Canada-Chile Free Trade Agreement (CCFTA)

Canada-Colombia Free Trade Agreement

Canada-European Union Comprehensive Economic and Trade Agreement(CETA)

Canada-Honduras Free Trade Agreement

Canada-Korea Free Trade Agreement

Canada-Panama Free Trade Agreement

Canada-Peru Free Trade Agreement (CPFTA)

Canadian Free Trade Agreement (CFTA)

Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP)

World Trade Organization Agreement on Government Procurement (WTO-AGP)

Canada-UK Trade Continuity Agreement (Canada-UK TCA)

Canada-Ukraine Free Trade Agreement

Details

Location

Ontario

Dates

Publication

2022/08/29 12:00:00 AM EDT

Closing Date

2022/10/11 02:00:00 PM EDT

Contact Information

Payeur, Marie-diane

819-939-8469

Marie-Diane.Payeur@forces.gc.ca

Description

Department of National Defence, has a requirement for Doxycycline Hyclate tablets or capsules of 100 mg for the treatment of Canadian Armed Forces (CAF) members who may have been exposed to bacterial biological warfare agents.

The period of the Contract is from date of Contract to 31 March 2026 inclusive.

Initial Requirement: The Contractor must supply 259,200 tablets or capsules of Doxycycline Hyclate (100 mg) no later than 31 March 2023.

Optional Requirements:

a) Optional Requirement 1: If exercised, the Contractor must supply up to 259,200 tablets or capsules of Doxycycline (100 mg) no later than 31 March 2024;

b) Optional Requirement 2: If exercised, the Contractor must supply up to 259,200 tablets or capsules of Doxycycline (100 mg) no later than 31 March 2025; and

c) Optional Requirement 3: If exercised, the Contractor must supply up to 259,200 tablets or capsules of Doxycycline (100 mg) no later than 31 March 2026.

Disclaimer Government of Canada (GC) tender notices and awards, solicitation documents and tender attachments are available free of charge and without registration on canadabuys.canada.ca/en/tender-opportunities, the authoritative location for GC tenders.

You may have received this tender notice or award through a third-party distributor. The Government of Canada is not responsible for any tender notices and/or related documents and attachments not accessed directly through canadabuys.canada.ca/en/tender-opportunities.

This Government of Canada tender notice or tender award carries an Open Government Licence - Canada that governs its use. Related solicitation documents and/or tender attachments are copyright protected. Please refer to the section about Commercial Reproduction in the canadabuys.canada.ca/en Terms and Conditions for more information.

Contains information licensed under the Open Government license - Canada. Contains data reproduced and distributed with the permission of the Government of Canada, on an "as is" basis.